UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The REWRITE Study – REal-WoRld effectIveness of TrifluridinE/tipiracil in Patients with Previously Treated Metastatic Colorectal Cancer

Clinical oncology (Royal College of Radiologists (Great Britain)), 2023-10, Vol.35 (10), p.665-672

2023

Volltextzugriff (PDF)

Long-Term Effect of the Portuguese Universal Access Program to New Generation Direct-Acting Antivirals for the Treatment of Hepatitis C

Journal of hepatology, 2016, Vol.64 (2), p.S778-S779

2016

Volltextzugriff (PDF)

Universal Access to New Generation Direct-Acting Antivirals to Reduce the Burden of Hepatitis C in Portugal

Journal of hepatology, 2016, Vol.64 (2), p.S816-S817

2016

Volltextzugriff (PDF)

Evidence of Impressive Real World SVR from the Portuguese Ledipasvir/Sofosbuvir and Sofosbuvir Universal Coverage Program to Eradicate (Eliminate) Hepatitis C

Journal of hepatology, 2016, Vol.64 (2), p.S224-S224

2016

Volltextzugriff (PDF)

Hospital Resource Utilization and Treatment Cost of Skeletal-Related Events in Patients with Metastatic Breast or Prostate Cancer: Estimation for the Portuguese National Health System

Value in health, 2011-06, Vol.14 (4), p.499-505

2011

Volltextzugriff (PDF)

PNS253 IS THERE STILL A REASON TO ARGUE FOR HIGHER DECISION-MAKING EFFICIENCY WITH SINATS? UPDATED ANALYSIS

Value in health, 2019-11, Vol.22, p.S804-S804

2019

Volltextzugriff (PDF)

POSB5 Real-World Patterns of Treatment and Dose Modification with CDKI 4/6 for Advanced Breast Cancer in Portugal

Value in health, 2022-01, Vol.25 (1), p.S25-S25

2022

Volltextzugriff (PDF)

PHP280 - IS THERE A REASON TO ARGUE FOR HIGHER DECISION-MAKING EFFICIENCY WITH SINATS?

Value in health, 2018-10, Vol.21, p.S197-S197

2018

Volltextzugriff (PDF)

PRM134 - USING ADJUSTED INDIRECT COMPARISON IN HTA TO OVERCOME SHORT FOLLOW-UP TIME IN REGULATORY RANDOMIZED CONTROLED CLINICAL TRIALS: RIBOCICLIB AS FIRST-LINE THERAPY FOR HR-POSITIVE, ADVANCED BREAST CANCER

Value in health, 2018-10, Vol.21, p.S379-S379

2018

Volltextzugriff (PDF)

PRM200 - STATED PREFERENCES FOR APPROPRIATE CHARACTERISTICS OF CURRENT HEPATITIS C TREATMENT REGIMENS

Value in health, 2018-10, Vol.21, p.S390-S390

2018

Volltextzugriff (PDF)

Maternal child-feeding practices and dietary inadequacy of 4-year-old children

Appetite, 2015-09, Vol.92, p.15-23

2015

Volltextzugriff (PDF)

PBI62 REAL-WORLD EVIDENCE ON THERAPEUTIC DRUG MONITORING OF TNF-INHIBITORS IN INFLAMMATORY BOWEL DISEASE

Value in health, 2019-11, Vol.22, p.S428-S428

2019

Volltextzugriff (PDF)

PCN145 - COST-EFFECTIVENESS OF NINTEDANIB FOR THE TREATMENT OF NON-SMALL LUNG CANCER IN PORTUGAL

Value in health, 2018-10, Vol.21, p.S39-S39

2018

Volltextzugriff (PDF)

PIN85 - TENOFOVIR ALAFENAMIDE’S IMPACT ON COMORBIDITIES AMONG PEOPLE LIVING WITH HIV IN PORTUGAL: A SIMULATION STUDY

Value in health, 2018-10, Vol.21, p.S235-S235

2018

Volltextzugriff (PDF)

PHP114 - THE ERRATIC AND LONG ACCESS JOURNEY OF ORPHAN DRUGS FROM EUROPE TO PORTUGAL

Value in health, 2018-10, Vol.21, p.S169-S169

2018

Volltextzugriff (PDF)

PHP96 - TIME EFFICIENCY IN THE REGULATORY DECISION-MAKING PROCESS OF ORPHAN DRUGS

Value in health, 2018-10, Vol.21, p.S166-S166

2018

Volltextzugriff (PDF)

PCV100 Real-World IMPACT of Sacubitril/Valsartan on the Quality of Life of Heart Failure Patients in Portugal

Value in health, 2020-12, Vol.23, p.S504-S505

2020

Volltextzugriff (PDF)

Pharmacoeconomics Of Ruxolitinib Therapy In Patients With Myelofibrosis

Value in health, 2015-11, Vol.18 (7), p.A456-A456

2015

Volltextzugriff (PDF)

PCN151 - Pharmacoeconomics Of Ruxolitinib Therapy In Patients With Myelofibrosis

Value in health, 2015-11, Vol.18 (7), p.A456-A456

2015

Volltextzugriff (PDF)

A Model-Based Meta-Analysis For The Effect of Metformin On Hba1c Levels In Patients With Type-2 Diabetes Mellitus

Value in health, 2017-10, Vol.20 (9), p.A474

2017

Volltextzugriff (PDF)

PDB3 - A Model-Based Meta-Analysis For The Effect of Metformin On Hba1c Levels In Patients With Type-2 Diabetes Mellitus

Value in health, 2017-10, Vol.20 (9), p.A474-A474

2017

Volltextzugriff (PDF)

SAT-178 - Long-Term Effect of the Portuguese Universal Access Program to New Generation Direct-Acting Antivirals for the Treatment of Hepatitis C

Journal of hepatology, 2016, Vol.64 (2), p.S778-S779

2016

Volltextzugriff (PDF)

LBP523 - Evidence of Impressive Real World SVR from the Portuguese Ledipasvir/Sofosbuvir and Sofosbuvir Universal Coverage Program to Eradicate (Eliminate) Hepatitis C

Journal of hepatology, 2016, Vol.64 (2), p.S224-S224

2016

Volltextzugriff (PDF)

SAT-256 - Universal Access to New Generation Direct-Acting Antivirals to Reduce the Burden of Hepatitis C in Portugal

Journal of hepatology, 2016, Vol.64 (2), p.S816-S817

2016

Volltextzugriff (PDF)

PSY12 - REAL-WORLD EFFECTIVENESS STUDY OF FERRIC CARBOXYMALTOSE IN ANAEMIC PATIENTS

Value in health, 2018-10, Vol.21, p.S437-S438

2018

Volltextzugriff (PDF)

1 – 25 von 132

Suche als RSS-Feed

Aktive Filter

KollektionElsevier ScienceDirect Journals Complete

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(131)
Mit Volltextzugriff
(129)

Publikationsform

Artikel
(132)

Sprache

Englisch
(131)
Französisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

The REWRITE Study – REal-WoRld effectIveness of TrifluridinE/tipiracil in Patients with Previously Treated Metastatic Colorectal Cancer

Long-Term Effect of the Portuguese Universal Access Program to New Generation Direct-Acting Antivirals for the Treatment of Hepatitis C

Universal Access to New Generation Direct-Acting Antivirals to Reduce the Burden of Hepatitis C in Portugal

Evidence of Impressive Real World SVR from the Portuguese Ledipasvir/Sofosbuvir and Sofosbuvir Universal Coverage Program to Eradicate (Eliminate) Hepatitis C

Hospital Resource Utilization and Treatment Cost of Skeletal-Related Events in Patients with Metastatic Breast or Prostate Cancer: Estimation for the Portuguese National Health System

PNS253 IS THERE STILL A REASON TO ARGUE FOR HIGHER DECISION-MAKING EFFICIENCY WITH SINATS? UPDATED ANALYSIS

POSB5 Real-World Patterns of Treatment and Dose Modification with CDKI 4/6 for Advanced Breast Cancer in Portugal

PHP280 - IS THERE A REASON TO ARGUE FOR HIGHER DECISION-MAKING EFFICIENCY WITH SINATS?

PRM134 - USING ADJUSTED INDIRECT COMPARISON IN HTA TO OVERCOME SHORT FOLLOW-UP TIME IN REGULATORY RANDOMIZED CONTROLED CLINICAL TRIALS: RIBOCICLIB AS FIRST-LINE THERAPY FOR HR-POSITIVE, ADVANCED BREAST CANCER

PRM200 - STATED PREFERENCES FOR APPROPRIATE CHARACTERISTICS OF CURRENT HEPATITIS C TREATMENT REGIMENS

Maternal child-feeding practices and dietary inadequacy of 4-year-old children

PBI62 REAL-WORLD EVIDENCE ON THERAPEUTIC DRUG MONITORING OF TNF-INHIBITORS IN INFLAMMATORY BOWEL DISEASE

PCN145 - COST-EFFECTIVENESS OF NINTEDANIB FOR THE TREATMENT OF NON-SMALL LUNG CANCER IN PORTUGAL

PIN85 - TENOFOVIR ALAFENAMIDE’S IMPACT ON COMORBIDITIES AMONG PEOPLE LIVING WITH HIV IN PORTUGAL: A SIMULATION STUDY

PHP114 - THE ERRATIC AND LONG ACCESS JOURNEY OF ORPHAN DRUGS FROM EUROPE TO PORTUGAL

PHP96 - TIME EFFICIENCY IN THE REGULATORY DECISION-MAKING PROCESS OF ORPHAN DRUGS

PCV100 Real-World IMPACT of Sacubitril/Valsartan on the Quality of Life of Heart Failure Patients in Portugal

Pharmacoeconomics Of Ruxolitinib Therapy In Patients With Myelofibrosis

PCN151 - Pharmacoeconomics Of Ruxolitinib Therapy In Patients With Myelofibrosis

A Model-Based Meta-Analysis For The Effect of Metformin On Hba1c Levels In Patients With Type-2 Diabetes Mellitus

PDB3 - A Model-Based Meta-Analysis For The Effect of Metformin On Hba1c Levels In Patients With Type-2 Diabetes Mellitus

SAT-178 - Long-Term Effect of the Portuguese Universal Access Program to New Generation Direct-Acting Antivirals for the Treatment of Hepatitis C

LBP523 - Evidence of Impressive Real World SVR from the Portuguese Ledipasvir/Sofosbuvir and Sofosbuvir Universal Coverage Program to Eradicate (Eliminate) Hepatitis C

SAT-256 - Universal Access to New Generation Direct-Acting Antivirals to Reduce the Burden of Hepatitis C in Portugal

PSY12 - REAL-WORLD EFFECTIVENESS STUDY OF FERRIC CARBOXYMALTOSE IN ANAEMIC PATIENTS

Aktive Filter

Suchergebnisse filtern